Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.


TSXV:KNE - Post by User

Bullboard Posts
Comment by pmrideron May 06, 2011 9:27am
187 Views
Post# 18539134

RE: RE: Kane future value per share

RE: RE: Kane future value per shareI'm with you drj.  Buy 1,000,000 shares in the market and i'll believe as well.  My assessment is that we could see something north of .40 by the mid summer if the general market hangs in.  Should we get our FDA approval come September, we should see something in the .60-.75 range.  The wild card will be what the FDA makes us do for trials.  At the moment, Kane is expecting trials to last up to a year, but there is an outside chance that the trials could be as short as 2 months. 

Now the real wild card, is that there have been many ongoing discussions with some respectable industry players and once some certainty is wrapped around this, the game will start in earnest.  That is when we could see the SP north of $1.00.  As for the $10.00 SP?  Come dream with me.
Bullboard Posts